1.Effects of (20 R)-Panaxadiol on NAFLD using non‑targeted metabolomics in stool. Journal of Pharmaceutical and Biomedical Analysis. 2023 Sep 20:234:115555. (2区),通讯作者 2.(20R)-Panaxadiol improves obesity by promoting white fat beigeing. Frontiers in Pharmacology. 2023. 14:1071516. (2区),通讯作者 3.Berberine mitigates hepatic insulin resistance by enhancing mitochondrial architecture via the SIRT1/Opa1 signalling pathway. Acta Biochim Biophys Sin. 2022, 54(10): 1-13. (2区),通讯作者 4. (20R)-Panaxadiol as a Natural Active Component with Anti-Obesity Effects on ob/ob Mice Via Modulating the Gut Microbiota. Molecules 2022, 27, 2502. 27082502. (2区) ,通讯作者 5.Amorphous solid dispersion of Berberine mitigates apoptosis via iPLA2β/ Cardiolipin/Opa1 pathway in db/db mice and in Palmitate- treated MIN6 β-cells. International Journal of Biological Sciences. 2019;15(7): 1533-1545.(2区), 通讯作者 |